Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

AEGON completes sale of EUR 1 billion RMBS notes

8th Jul 2010 07:00

NOT FOR DISTRIBUTION IN THE USA

AEGON successfully completes sale of EUR 1 billion `SAECURE 7' RMBS notes

AEGON announces that is has successfully completed the sale of EUR 1,017,500,000 Class A residential mortgage-backed securities* (RMBS) in a private placement with institutional investors.

These securities are expected to have a weighted average life of 4.3 years and are priced at par with a coupon of three month Euribor plus 1.35%. The securities were issued under the Dutch SAECURE program**.

The net proceeds will be used to finance a part of the existing Dutch mortgage portfolio of AEGON.

AEGON is pleased it was able to successfully complete the sale despite challenging market conditions. SAECURE continues to be regarded as a top tier program in the Dutch RMBS market. AEGON's proven underwriting criteria and servicing have led to high quality performance on the company's outstanding SAECURE transactions.

J.P. Morgan acted as sole arranger and manager for this SAECURE 7 transaction.

* The securities are rated AAA by Standard & Poor's, Aaa by Moody's Investor Service and AAA by Fitch.

** The SAECURE program is managed by AEGON's subsidiary AEGON Levensverzekering N.V.

Contact informationMedia relations: Greg Tucker+31(0)70 344 [email protected]

Investor relations: Gerbrand Nijman

+31 (0)70 344 8305

877 548 9668 - toll free USA only

[email protected] AEGON

As an international life insurance, pension and investment company based in The Hague, AEGON has businesses in over twenty markets in the Americas, Europe and Asia. AEGON companies employ approximately 28,000 people and have some 40 million customers across the globe.

Key figures - EUR First quarter Full year 2010 2009 Underlying earnings 488 million 1.2 billionbefore tax New life sales 538 million 2.1 billion Gross deposits (excl. 7.8 billion 28 billionrun-off) Revenue generating 388 billion 363 billioninvestments (end of period) Forward-looking statements

The statements contained in this press release that are not historical facts are forward-looking statements as defined in the US Private Securities Litigation Reform Act of 1995. The following are words that identify such forward-looking statements: aim, believe, estimate, target, intend, may, expect, anticipate, predict, project, counting on, plan, continue, want, forecast, goal, should, would, is confident, will, and similar expressions as they relate to our company. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. We undertake no obligation to publicly update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which merely reflect company expectations at the time of writing. Actual results may differ materially from expectations conveyed in forward-looking statements due to changes caused by various risks and uncertainties. Such risks and uncertainties include but are not limited to the following:

* Changes in general economic conditions, particularly in the United States, the Netherlands and the United Kingdom; * Changes in the performance of financial markets, including emerging markets, such as with regard to: - The frequency and severity of defaults by issuers in our fixed income investment portfolios; and - The effects of corporate bankruptcies and/or accounting restatements on the financial markets and the resulting decline in the value of equity and debt securities we hold; * The frequency and severity of insured loss events; * Changes affecting mortality, morbidity and other factors that may impact the profitability of our insurance products; * Changes affecting interest rate levels and continuing low or rapidly changing interest rate levels; * Changes affecting currency exchange rates, in particular the EUR/USD and EUR/GBP exchange rates; * Increasing levels of competition in the United States, the Netherlands, the United Kingdom and emerging markets; * Changes in laws and regulations, particularly those affecting our operations, the products we sell, and the attractiveness of certain products to our consumers; * Regulatory changes relating to the insurance industry in the jurisdictions in which we operate; * Acts of God, acts of terrorism, acts of war and pandemics; * Effects of deliberations of the European Commission regarding the aid we received from the Dutch State in December 2008; * Changes in the policies of central banks and/or governments; * Lowering of one or more of our debt ratings issued by recognized rating organizations and the adverse impact such action may have on our ability to raise capital and on our liquidity and financial condition; * Lowering of one or more of insurer financial strength ratings of our insurance subsidiaries and the adverse impact such action may have on the premium writings, policy retention, profitability of its insurance subsidiaries and liquidity; * The effect of the European Union's Solvency II requirements and other regulations in other jurisdictions affecting the capital we are required to maintain; * Litigation or regulatory action that could require us to pay significant damages or change the way we do business; * Customer responsiveness to both new products and distribution channels; * Competitive, legal, regulatory, or tax changes that affect the distribution cost of or demand for our products; * The impact of acquisitions and divestitures, restructurings, product withdrawals and other unusual items, including our ability to integrate acquisitions and to obtain the anticipated results and synergies from acquisitions; * Our failure to achieve anticipated levels of earnings or operational efficiencies as well as other cost saving initiatives; and * The impact our adoption of the International Financial Reporting Standards may have on our reported financial results and financial condition.

Further details of potential risks and uncertainties affecting the company are described in the company's filings with Euronext Amsterdam and the US Securities and Exchange Commission, including the Annual Report on Form 20-F. These forward-looking statements speak only as of the date of this document. Except as required by any applicable law or regulation, the company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

Press release

JULY 8, 2010

vendor

Related Shares:

Aegon Ord
FTSE 100 Latest
Value8,275.66
Change0.00